OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring lectin–glycan interactions to combat COVID-19: Lessons acquired from other enveloped viruses
Luís Cláudio Nascimento da Silva, Juliana Silva Pereira Mendonça, Weslley Felix de Oliveira, et al.
Glycobiology (2020) Vol. 31, Iss. 4, pp. 358-371
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

The glycosylation in SARS-CoV-2 and its receptor ACE2
Yanqiu Gong, Suideng Qin, Lunzhi Dai, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 166

Seaweeds as a Source of Functional Proteins
Punniamoorthy Thiviya, Ashoka Gamage, Nalin Suranjith Gama-Arachchige, et al.
Phycology (2022) Vol. 2, Iss. 2, pp. 216-243
Open Access | Times Cited: 87

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62

SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
Ahmed M. Almehdi, Ghalia Khoder, Aminah Alchakee, et al.
Infection (2021) Vol. 49, Iss. 5, pp. 855-876
Open Access | Times Cited: 86

Lectins and lectibodies: potential promising antiviral agents
Mohsen Nabi‐Afjadi, Morteza Heydari, Hamidreza Zalpoor, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 42

Inhibition of Protein N- Glycosylation Blocks SARS-CoV-2 Infection
Aitor Casas-Sánchez, Alessandra Romero-Ramirez, E. R. Hargreaves, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38

Mannose-specific plant and microbial lectins as antiviral agents: A review
Ankita Gupta, Kusum Yadav, Anurag Yadav, et al.
Glycoconjugate Journal (2024) Vol. 41, Iss. 1, pp. 1-33
Closed Access | Times Cited: 10

C-type lectins and extracellular vesicles in virus-induced NETosis
Pei‐Shan Sung, Shie‐Liang Hsieh
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 41

Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
Corbin England, Jonathan TrejoMartinez, Paula PerezSanchez, et al.
Life (2023) Vol. 13, Iss. 3, pp. 617-617
Open Access | Times Cited: 15

SARS-CoV-2 spike protein in infectivity
Alaa Muayad Altaie, Rania Hamdy, Mohamed I. Husseiny, et al.
Elsevier eBooks (2025), pp. 21-56
Closed Access

Seaweed-Based Proteins and Peptides: Processing and Development of Innovative Products
Armin Mirzapour‐Kouhdasht, Samaneh Shaghaghian, Marco García‐Vaquero
(2025), pp. 227-249
Closed Access

Research advances and prospects of legume lectins
Rajan Katoch, Ankur Tripathi
Journal of Biosciences (2021) Vol. 46, Iss. 4
Open Access | Times Cited: 37

Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies
Md Nasir Ahmed, Rownak Jahan, Veeranoot Nissapatorn, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112507-112507
Open Access | Times Cited: 25

A novel plant lectin, NTL-125, interferes with SARS-CoV-2 interaction with hACE2
Anindya Sarkar, Sathi Paul, Charandeep Singh, et al.
Virus Research (2022) Vol. 315, pp. 198768-198768
Open Access | Times Cited: 12

Lectins from plants and algae act as anti-viral against HIV, influenza and coronaviruses
Sanjay Naik, Sanjit Kumar
Molecular Biology Reports (2022) Vol. 49, Iss. 12, pp. 12239-12246
Open Access | Times Cited: 11

Research advances and prospects of legume lectins.
Rajan Katoch, Ankur Tripathi
PubMed (2021) Vol. 46
Closed Access | Times Cited: 12

Current status of microbial lectins in biomedical research
Rojita Mishra, Rashi Miglani, Kulbhushan Kumar, et al.
Elsevier eBooks (2023), pp. 59-79
Closed Access | Times Cited: 3

Glycan-lectin interactions powered biosensors for the instant screening of viruses and beyond
Mengnan Li, Haijie Ji, Yuhan Wang, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 167, pp. 117243-117243
Open Access | Times Cited: 3

Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery
Morteza Rabiei, Soheila Kashanian, Seyedeh Sabereh Samavati, et al.
Journal of drug targeting (2021) Vol. 30, Iss. 3, pp. 233-243
Closed Access | Times Cited: 8

Molecular basis of N-glycan recognition by pradimicin a and its potential as a SARS-CoV-2 entry inhibitor
Yu Nakagawa, Masato Fujii, N. Ito, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 105, pp. 117732-117732
Closed Access

Leveraging Lucrative Lectins: An Explorative Review of the Biomedical Properties of Lectins
Preetha Nair -, Saranya Jayaram -
International Journal For Multidisciplinary Research (2024) Vol. 6, Iss. 3
Open Access

CIDER: Counterfactual-Invariant Diffusion-based GNN Explainer for Causal Subgraph Inference
Q. Zhang, Chengshang Lyu, Lingxi Chen, et al.
Research Square (Research Square) (2024)
Open Access

Nutraceuticals in Legumes
Rajan Katoch, Ankur Tripathi, Neelam Thakur, et al.
(2024), pp. 229-250
Closed Access

Page 1 - Next Page

Scroll to top